Jupiter Life Line Hospitals Li

BSE: 543980 30 Sep 2025

Healthcare

₹ 1524.6

Jupiter Life Line Hospitals Limited specializes in Hospital within the Healthcare sector.

Jupiter Life Line Hospitals Li

BSE: 543980 30 Sep 2025

Healthcare

₹ 1524.6

Jupiter Life Line Hospitals Limited specializes in Hospital within the Healthcare sector.

Book Value

207.0

Dividend Yield

0.07%

Debt to Equity

0.29

Stock P/E

51.4

Market Cap

9,903 Cr

Jupiter Life Line Hospitals Li - Share Price & Details

Market Cap

₹9,903

High /Low

1,770 / 1,250

Stock P/E

51.4

Book Value

₹207.0

Dividend Yield

0.07

ROCE

18.0

ROE

₹15.0

Face Value

10.0

PEG Ratio

0.94

EVEBITDA

₹28.5

Debt

393

CMP / FCF

10,692

Debt to equity

₹0.29

NP Ann

194

High price all time

1,770

Piotroski score

₹6.0

Graham Number

370.0

No. Eq. Shares

6.56

Net CF

₹345

Net profit

193

Price to book value

7.3

Interest Coverage

₹15.6

Low price all time

960.0

Industry PE

57.5

Reserves

₹1,291

Free Cash Flow

₹-67.0

Broker Recommendations

Date	Author	Type	Reco Price	Target Price	Potential	Source	PDF Link
05 Aug 2025	Prabhudas Lilladher	Buy	₹1,450.05	₹1,720	21.9%	moneycontrol	View
04 Aug 2025	Anand Rathi	Buy	₹1,450.05	₹1,750	24%	moneycontrol	View
10 Feb 2025	Prabhudas Lilladher	Buy	₹1,564.65	₹1,750	17.3%	moneycontrol	View
10 Feb 2025	Anand Rathi	Buy	₹1,564.65	₹1,740	12.9%	moneycontrol	View
09 Feb 2025	ICICI Securities	Hold	₹1,587.55	₹1,610	7.2%	moneycontrol	View
12 Nov 2024	AnandRathi	Buy	₹1,544.45	₹1,740	16%	moneycontrol	View
12 Nov 2024	Prabhudas Lilladher	Buy	₹1,544.45	₹1,660	10.6%	moneycontrol	View
13 May 2024	Prabhudas Lilladher	Buy	₹1,274.2	₹1,360	-9%	moneycontrol	View

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.09	84.8
Triochem Products Ltd.,	NA	NA	NA	NA	0
Jupiter Life Line Hospitals Li	2908.23	432.94	2779.42	6.6	9,903	51.4
HealthCare Global Enterprises	NA	NA	NA	NA	9128	246.0
SHILPA MEDICARE LTD.	1102.23	206.97	924.33	2.12	7548	58.7

Peer Comparison Chart

About Jupiter Life Line Hospitals Li

Jupiter Life Line Hospitals Limited, with Security Code 543980, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.

Order Book

Latest News

Jupiter Life Line Hospitals’ revenue increases 20%; PAT dips 1.4% in Q1FY26

(16 Aug 2025)

Jupiter Life Line Hospitals Ltd announced the financial results for the first quarter of the financial year 2026.

Jupiter Life Line Hospitals to Attend Investor Conference in Mumbai

(12 Aug 2025)

An update from Jupiter Life Line Hospitals Ltd. ( ($IN:JLHL) ) is now available. Jupiter Life Line Hospitals Ltd. announced its participation in an...

Jupiter Life Line Hospitals Limited (JLHL)’s Trend in 2025 - Consistently outstanding ROI

(06 Aug 2025)

Jupiter Life Line Hospitals Limited (JLHL)'s Trend in 2025 ✌️【Market Watch】✌️ Our professional team monitors stock trends and market shifts...

Buy Jupiter Lifeline Hospital; target of Rs 1750: Anand Rathi

(06 Aug 2025)

Anand Rathi is bullish on Jupiter Lifeline Hospital has recommended buy rating on the stock with a target price of Rs 1750 in its research...

Jupiter Life Line’s Q1 profit slips 1.4% YoY to ₹43.8 crore

(06 Aug 2025)

Jupiter Life Line Hospitals Ltd reported a steady operational performance for the June quarter, even as profit edged slightly lower.

Jupiter Life Line Hospitals Faces Technical Shift Amid Flat Financial Performance

(31 Jul 2025)

Jupiter Life Line Hospitals has recently experienced an evaluation adjustment reflecting changes in its technical trends, shifting to a mildly bearish stance.

Quarterly Table

Standalone Consolidated

Metrics	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Sales	207.9	227.1	230.4	245.3	239.4	273.1	269.1	273.9	277.9
Expenses	156.7	168.3	173.3	188.9	183.7	203.7	201.7	201.6	210.4
Operating Profit	51.1	58.8	57.1	56.4	55.7	69.4	67.4	72.3	67.5
OPM %	24.6%	25.89%	24.76%	22.98%	23.26%	25.43%	25.06%	26.39%	24.3%
Other Income	5.4	5.4	7.8	11.0	8.2	9.3	8.1	7.0	12.9
Interest	8.2	8.5	1.0	0.9	0.9	1.0	2.7	4.0	3.0
Depreciation	7.8	7.6	7.7	7.5	8.0	10.4	10.6	13.4	16.7
Profit before tax	42.0	48.8	56.3	56.7	55.0	67.3	62.3	61.9	60.8
Tax %	-25%	-24.8%	-24.8%	-26.9%	-26.1%	-25.3%	-20.8%	-28%	28.7%
Net Profit	30.4	36.1	42.2	43.1	40.7	50.3	49.3	44.4	43.3
EPS in Rs	5.76	6.18	6.48	6.47	6.2	7.67	7.52	0	6.6

Metrics	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	243.2	263.2	272.6	290.5	287.1	322.6	320.6	326.7
Expenses	190.2	202.1	210.8	228.2	223.3	247.6	245.6	248.4
Operating Profit	53.0	61.0	61.9	62.3	63.9	75.0	75.0	78.3
OPM %	21.79%	23.19%	22.69%	21.44%	22.24%	23.25%	23.39%	23.97%
Other Income	3.6	3.2	7.9	11.2	8.4	9.4	8.3	7.0
Interest	12.2	12.2	1.0	0.9	1.1	1.1	2.8	5.6
Depreciation	10.7	10.6	10.7	10.4	11.0	14.4	14.0	17.6
Profit before tax	35.1	42.1	58.2	59.9	60.1	68.9	66.6	62.2
Tax %	59.9%	-18.6%	-24.8%	-27.2%	25.8%	25.2%	21.1%	-27.7%
Net Profit	54.0	33.7	43.7	45.3	44.6	51.5	52.5	44.9
EPS in Rs	9.93	5.67	6.56	6.49	6.8	7.86	8.01	0

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	0%
5 Years:	18%
3 Years:	17%
TTM:	16%

Compounded Profit Growth
10 Years:	0%
5 Years:	44%
3 Years:	30%
TTM:	22%

Stock Price CAGR
10 Years:	0%
5 Years:	0%
3 Years:	0%
1 Year:	26%

Compounded Sales Growth
10 Years:	0%
5 Years:	22%
3 Years:	20%
TTM:	18%

Compounded Profit Growth
10 Years:	0%
5 Years:	44%
3 Years:	56%
TTM:	9%

Stock Price CAGR
10 Years:	0%
5 Years:	0%
3 Years:	0%
1 Year:	26%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

Stock Mutual Funds Data

Order Book

News Date ▲▼	Headline ▲▼	Issuer Entity ▲▼	Issuer Type ▲▼	Order Size ▲▼	Time Period ▲▼
Loading company updates…

Loading technicals…

Moving Averages

Latest Close: — • Records Used: — • Last Trading Date: —

Simple Moving Averages (SMA)

Period	SMA Value	Status

Exponential Moving Averages (EMA)

Period	EMA Value	Status

Oscillators

Key Oscillators

latest calculation

Indicator	Value

Jupiter Life Line Hospitals Li

Jupiter Life Line Hospitals Li

Jupiter Life Line Hospitals Li - Share Price & Details

Broker Recommendations

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About Jupiter Life Line Hospitals Li

Order Book

Latest News

Jupiter Life Line Hospitals’ revenue increases 20%; PAT dips 1.4% in Q1FY26

Jupiter Life Line Hospitals to Attend Investor Conference in Mumbai

Jupiter Life Line Hospitals Limited (JLHL)’s Trend in 2025 - Consistently outstanding ROI

Buy Jupiter Lifeline Hospital; target of Rs 1750: Anand Rathi

Jupiter Life Line’s Q1 profit slips 1.4% YoY to ₹43.8 crore

Jupiter Life Line Hospitals Faces Technical Shift Amid Flat Financial Performance

Jupiter Life Line Hospitals Limited (JLHL) Signs Major Deal - Extraordinary performance

Jupiter Life Line Hospitals consolidated net profit declines 1.42% in the June 2025 quarter

Jupiter Life Line Hospitals Limited (JLHL)’s Trend in 2025 - Consistent high-yield stocks

Is Jupiter Life Line Hospitals Limited (543980) a Good Long Term Bet - Overwhelming profit margins

Jupiter Life Line Hospitals Limited (JLHL) Signs Major Deal - Free Stock Market Trend Analysis

Jupiter Life Line Hospitals Limited (543980) Expands into New Market - Market-beating returns

Jupiter Life Line Hospitals Limited (543980) Gets Regulatory Approval - Breakout stock performance

Jupiter Life Line Hospitals Faces Bearish Technical Trends Amid Market Evaluation Revision

Jupiter Life Line Hospitals Faces Significant Stock Decline Amid Broader Market Gains

Jupiter Life Line plans three new hospitals, eyes more complex surgeries in Indore

Jupiter Life Line Hospitals revenue up 12.1%; PAT down 0.9% in Q4FY25

Jupiter Life Line Hospitals' (NSE:JLHL) Solid Earnings May Rest On Weak Foundations

Jupiter Life Line Hospitals Reports Flat Financial Performance Amid Technical Adjustments

Buy Jupiter Life Line Hospitals; target of Rs 1720: Prabhudas Lilladher

BOARD OF JUPITER LIFE LINE HOSPITALS RECOMMENDS FINAL DIVIDEND

Board of Jupiter Life Line Hospitals appoints Dr. Ankit Thakker as Jt. MD and CEO

Jupiter Life Line Hospitals consolidated net profit declines 0.42% in the March 2025 quarter

Jupiter Life Line Hospitals: Strong Operation Strategy

Jupiter Life Line Hospitals takes the road less travelled

Jupiter Life Line Hospitals Faces Volatility Amidst Strong Long-Term Performance Trends

Jupiter Life Line Hospitals Faces Continued Decline Amid Broader Market Weakness

Resilient and Debt-Free Hospital Stock Gains 3% Amid Corporate Restructuring

Hold Jupiter Life Line Hospitals: target of Rs 1610: ICICI Securities

Jupiter Life Line Hospitals Limited (NSE:JLHL) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Jupiter Hospitals acquires land for new hospital in Thane, Maharashtra with ₹400 cr capex plans

Jupiter Hospital to invest Rs 400 crore to set up new hospital in Ghodbunder-Mira Road

The Trend Of High Returns At Jupiter Life Line Hospitals (NSE:JLHL) Has Us Very Interested

Jupiter Life Line Hospitals Reports 21.24% Operating Profit Growth in Q2 FY24-25

Jupiter Life Line Hospitals targets doubling revenue in 3-5 years with new beds

Jupiter Life Line Hospitals - These 4 stocks hit 52-week highs, rallied up to 45% in a month

Jupiter Life Line Hospitals Downgraded to 'Hold' by MarketsMOJO, But Shows Strong Financial Performance and Potential for Growth

Jupiter Life Line Hospitals: A Midcap Company with Strong Fundamentals and Positive Outlook

Jupiter Hospitals’ new facility in Dombivli to be operational by 2026

Jupiter Life Line Hospitals (NSE:JLHL) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Jupiter Life Line Hospitals' Stock Sees Positive Trend, Outperforms Sector by 3.77%

Buy Jupiter Lifeline Hospital; target of Rs 1740: Anand Rathi

Revenue Beat: Jupiter Life Line Hospitals Limited Exceeded Revenue Forecasts By 5.2% And Analysts Are Updating Their Estimates

Buy Jupiter Life Line Hospitals target of Rs 1660: Prabhudas Lilladher

Jupiter Life Line Hospitals consolidated net profit rises 52.94% in the September 2024 quarter

Here's Why We Think Jupiter Life Line Hospitals (NSE:JLHL) Might Deserve Your Attention Today

Jupiter Life Line Hospitals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024

LIC, SBI, Tata Motors, Ashok Leyland, MRF, Jupiter Wagons Q2 Results Today — Earnings Estimates

Buy Jupiter Life Line Hospitals; target of Rs 1475: Prabhudas Lilladher

Jupiter Lifeline Q1 Review- Good Start To FY25 With All Three Units Doing Well; Maintaining A Buy: Anand Rathi

Jupiter Life Line Hospitals Limited (NSE:JLHL) Just Released Its First-Quarter Earnings: Here's What Analysts Think

Jupiter Life Line Hospitals Q1FY25: Revenue Rs 2,871.25M, PAT Rs 446.05M

Jupiter Life Line eyes 17-18% topline growth for FY25

Jupiter Life Line Hospitals First Quarter 2025 Earnings: EPS: ₹6.80 (vs ₹9.93 in 1Q 2024)

Jupiter Life Line Hospitals consolidated net profit declines 17.39% in the June 2024 quarter

JM Financial Recommends Buying Jupiter Life Line Hospitals, Sets Target Price at Rs 1515

Buy Jupiter Life Line Hospitals, target price Rs 1515: JM Financial

Can Jupiter Life Line Hospitals Ensure Healthy Gains Over The Long Term? Stocks For The Next Innings

Jupiter Life Line Hospitals Ltd | Stock Share Price Live

Jupiter Life Line Hospitals Q4 review: Greenfield expansion to drive growth

Jupiter Life Line Hospitals Q4 Results Review - Inline; Margins To Improve: Prabhudas Lilladher

Jupiter Life Line shares rise over 7% on strong Q4 performance

Jupiter Life Line Hospitals to set up new 500-bed hospital in Pune this year

Jupiter Life Line Hospitals Full Year 2024 Earnings: EPS Beats Expectations

Jupiter Life Line Hospitals Bonus

Jupiter Life Line Hospitals Share Price Today - Jupiter Life Line Hospitals Stock Price Live NSE/BSE

Jupiter Hospital share price opens at 32.4% premium on NSE

Jupiter Life Line Hospitals' Stock Reaches All-Time High, Rated as 'Buy' by MarketsMOJO

Declining Stock and Decent Financials: Is The Market Wrong About Jupiter Life Line Hospitals Limited (NSE:JLHL)?